125 related articles for article (PubMed ID: 23337894)
1. Biomarkers for cardiovascular risk in children.
Canas JA; Sweeten S; Balagopal PB
Curr Opin Cardiol; 2013 Mar; 28(2):103-14. PubMed ID: 23337894
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle intervention.
Montero D; Walther G; Perez-Martin A; Roche E; Vinet A
Obes Rev; 2012 May; 13(5):441-55. PubMed ID: 22133012
[TBL] [Abstract][Full Text] [Related]
5. Childhood obesity and cardiovascular dysfunction.
Cote AT; Harris KC; Panagiotopoulos C; Sandor GG; Devlin AM
J Am Coll Cardiol; 2013 Oct; 62(15):1309-19. PubMed ID: 23954339
[TBL] [Abstract][Full Text] [Related]
6. Circulating biomarkers.
Badimon L; Romero JC; Cubedo J; Borrell-Pagès M
Thromb Res; 2012 Oct; 130 Suppl 1():S12-5. PubMed ID: 23026650
[TBL] [Abstract][Full Text] [Related]
7. Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome.
Mansoub S; Chan MK; Adeli K
Clin Biochem; 2006 Jun; 39(6):569-87. PubMed ID: 16624272
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
Misra A; Khurana L
Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
[TBL] [Abstract][Full Text] [Related]
9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
10. Obesity, metabolic syndrome, and cardiovascular disease.
Aggoun Y
Pediatr Res; 2007 Jun; 61(6):653-9. PubMed ID: 17426660
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
Müller A; Mulhall JP
Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
[TBL] [Abstract][Full Text] [Related]
12. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
l'Allemand-Jander D
Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
[TBL] [Abstract][Full Text] [Related]
13. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
14. Obesity and cardiovascular disease: from pathophysiology to risk stratification.
Marinou K; Tousoulis D; Antonopoulos AS; Stefanadi E; Stefanadis C
Int J Cardiol; 2010 Jan; 138(1):3-8. PubMed ID: 19398137
[TBL] [Abstract][Full Text] [Related]
15. Obesity and endothelial dysfunction.
Shankar SS; Steinberg HO
Semin Vasc Med; 2005 Feb; 5(1):56-64. PubMed ID: 15968581
[TBL] [Abstract][Full Text] [Related]
16. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
17. Vascular disease and chronic renal failure: new insights.
Nanayakkara PW; Gaillard CA
Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein(a) levels and body mass index correlate with family history of cardiovascular disease.
Glowinska B; Urban M; Koput A
Eur J Pediatr; 2002 Oct; 161(10):511-8. PubMed ID: 12297895
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
20. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
